Phase 4 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 35 and 65 years old, of any gender
- People diagnosed with mild (Grade 1) high blood pressure
- People who are either not currently taking any blood pressure medication, or who have been taking it inconsistently in the past
- People who are willing to sign a consent form agreeing to take part
Who may not be able to join:
- People with significant liver or kidney problems, including certain abnormal blood test results related to liver or kidney function
- People with digestive or stomach conditions that could affect how the body absorbs medication
- People who have a known allergy to the medication being used in this trial
- Women who are pregnant or breastfeeding, and men who are planning to father a child within the next six months
- People who have other serious major illnesses or any form of cancer
- People who have high cholesterol or high blood fats, whether or not they are taking medication for it
- People with certain heart or blood vessel changes, such as an enlarged heart muscle, reduced blood flow in the legs, or thickening or build-up of fatty deposits in the artery walls (confirm with trial site for exact measurements)
- People who have complications related to high blood pressure, including stroke-related conditions, other heart conditions, kidney disease, peripheral artery disease, eye damage from high blood pressure, or diabetes
- People with other serious health conditions that the trial team considers unsuitable for participation (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hao Xu, Prof., Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phone: 010-62835342
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in the Mean 24h Systolic Blood Pressure at 4,12 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.